Swiss National Bank Has $5.81 Million Position in Amedisys, Inc. (NASDAQ:AMED)

Swiss National Bank lessened its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 61,100 shares of the health services provider's stock after selling 10,600 shares during the quarter. Swiss National Bank owned approximately 0.19% of Amedisys worth $5,808,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Cetera Trust Company N.A purchased a new position in Amedisys during the fourth quarter worth about $215,000. CWM LLC boosted its position in shares of Amedisys by 40.4% in the fourth quarter. CWM LLC now owns 2,629 shares of the health services provider's stock worth $250,000 after acquiring an additional 757 shares during the last quarter. Contravisory Investment Management Inc. purchased a new stake in Amedisys in the fourth quarter valued at approximately $258,000. Argonautica Private Wealth Management Inc. grew its holdings in Amedisys by 6.1% in the third quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider's stock valued at $280,000 after purchasing an additional 172 shares during the period. Finally, Federated Hermes Inc. increased its position in Amedisys by 32.9% during the fourth quarter. Federated Hermes Inc. now owns 3,518 shares of the health services provider's stock worth $334,000 after purchasing an additional 871 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Stock Down 0.5 %

Shares of NASDAQ:AMED traded down $0.52 during mid-day trading on Friday, hitting $94.43. 196,778 shares of the company traded hands, compared to its average volume of 273,020. The firm's 50 day simple moving average is $92.61 and its 200 day simple moving average is $93.49. The firm has a market cap of $3.09 billion, a P/E ratio of -147.54, a PEG ratio of 3.55 and a beta of 0.84. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. Amedisys, Inc. has a 52-week low of $74.61 and a 52-week high of $96.44.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.02 by $0.01. The company had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business's quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.00 earnings per share. On average, equities analysts anticipate that Amedisys, Inc. will post 4.57 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AMED. Raymond James reissued a "market perform" rating on shares of Amedisys in a research note on Tuesday, March 26th. Cantor Fitzgerald restated a "neutral" rating and set a $101.00 price target on shares of Amedisys in a research note on Thursday, April 25th. Royal Bank of Canada lifted their price objective on Amedisys from $97.00 to $100.00 and gave the company an "outperform" rating in a research note on Monday, March 25th. Finally, StockNews.com raised shares of Amedisys from a "hold" rating to a "buy" rating in a research report on Saturday, May 4th. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Amedisys has a consensus rating of "Hold" and a consensus target price of $100.80.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.